Clearance of inflammatory mediators through continuous renal replacement therapy

Blood Purification

Volumn 15, Issue 4-6, 1997, Pages 305-308

  Montoliic, Jesús ^a  

^a UNIVERSITY OF LLEIDA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CONFERENCE PAPER; HEMOFILTRATION; INFLAMMATION; KIDNEY TRANSPLANTATION; MEDIATOR; MULTIPLE ORGAN FAILURE; PRIORITY JOURNAL; SEPSIS;

ANIMALS; HUMANS; INFLAMMATION MEDIATORS; KIDNEY FAILURE, ACUTE; MULTIPLE ORGAN FAILURE; RENAL REPLACEMENT THERAPY;

EID: 0030842195     PISSN: 02535068     EISSN: 14219735     Source Type: Journal    
DOI: 10.1159/000170348     Document Type: Article

References (22)

1. Kramer P, Wigger P, Rieger J: Arteriovenous hemofiltration: A new and simple method for treatment of overhy-drated patients resistant to diuretics. Klin Wochcnschr 1977;55:1121-1122.
2. Schetz M. Ferdinande P. Van der Berghe G, Verwaest C, Lauwers P: Removal of proinflammatory cytokines with renal replacement therapy: Sense or nonsense. Intens Care Med 1995;21: 169-176.
3. Casey LC: Role of cytokines in the pathogenesis of cardiopulmonary-induced multisystem organ failure. Ann ThoracSurg 1993:56:92-96.
4. Millar AB, Armstrong L, Van der Linden J. et al: Cytokine production and hemofiltration in children undergoing cardiopulmonary bypass. Ann Thorac Surg 1993;56:1499-1502.
5. Bellomo R, Tipping P, Boyce N: Continuous veno-venous hemofiltration with dialysis removes cytokines from the circulation of septic patients. Crit Care Med 1993:21:522-526.
6. Joumois D, Pouard P, Greely WJ, Mauriat P, Vouhe P, Safran D: Hemofiltration during cardiopulmonary bypass in pediatric cardiac surgery: Effects on hemostasis, cytokines and complement components. Anesthesiology 1994;81:1181-1189.
7. Ronco C, Tetta C, Lupi A, et al: Removal of platelet activating factor in experimental arteriovenous hemofiltration. Crit Care Med 1995:23:99-107.
8. Andreasson S, Gothberg S. Bcrggrcn H. Bengtsson A, Eriksson E. Risberg B: Hemofiltration modifies complement activation after extracorporeal circulation in infants. Ann Thorac Surg 1993: 56:1515-1517.
9. Barrera P, Janssen EM, Demacker PN, Wetzels JF, van der Mecr JW: Removal of interleukin-1 beta and tumor necrosis factor from human plasma by in vitro dialysis with polyacrylonitrile membranes. Lymphokine Cytokine Res 1992;11:99-104.
10. Bazzoni F, Beutler B: The tumor necrosis factor ligand and receptor families. N Engl J Med 1996:334:1717-1725.
11. Stein B, Pfenninger E, Gruncrt A. Schmitz JE. Hudde M: Influence of continuous hemofiltration on hemodynamics and central blood volume in experimental endotoxic shock. Intensive Care Med 1990; 16:494-499.
12. Grootendorst AF, van Bommel EF, van der Hoven B, van Leengoed LA, van Osta AL: High volume ultrafiltration improves right ventricular function in endotoxin-induced shock in the pig. Intens Care Med 1992:18:235-240.
13. Storck M, Hartl WH, Zimmercr E, In-thom D: Comparison of pump driven and spontaneous haemofiltration in postoperative acute renal failure. Lancet 1991;337:452-455.
14. Joumois D. Chanu D. Safran D: Pump-driven hemofiltration. Lancet 1991:337:985.
15. Casey LC: Role of cytokines in the pathogenesis of cardiopulmonary-induced multisystem organ failure. Ann Thorac Surg 1993:56:92-96.
16. Fisher C Jr, Opal SM, Dhainaut JF. et al: Influence of an anti-tumor necrosis factor monoclonal antibody on cytokine levels in patients with sepsis. The CB 0006 Sepsis Syndrome Study Group. Crit Care Med 1993:21:318-327.
17. Fisher C Jr. Opal SM. Dhainaut JF, et al: Recombinant human interleukin 1 receptor antagonist in the treatment of patients with sepsis syndrome. Results from a randomized, double blind, placebo-controlled trial. Phase III rh IL-Ira Sepsis Syndrome Study Group. JAMA 1994;271:1836-1843.
18. Fisher CJ Jr, Agosti JM, Opal SM, et al: Trcatment of septic shock with the tumor necrosis factor receptor: Fc fusion protein. N Engl J Med 1996:334:1697-1702.
19. Fekade D. Knox K. Hussein K. et al: Prevention of Jarisch-Herxheimcr reactions by treatment with antibodies against tumor necrosis factor alpha. N Engl J Med 1996:335:311-315.
20. Beutler B, Munford RS: Tumor necrosis factor and the Jarisch-Herxhcimer reaction. N Engl J Med 1996:335:347- 348.
21. Joumois D. Silvester W: Continuous hemofiltration in patients with sepsis or multiorgan failure. Semin Dialysis 1996;9:173-178.
22. de Waal Malefyt, Abrams J, Bennet B, Figdor CG, de Vries JE: Interleukin-10 inhibits cytokine synthesis by human monocytes: An autoregulatory role of IL-10 produced by monocytes. J Exp Med 1991;174:1209-1220.